Canterbury DHB
don't forget to update the issue and next review variables!!!
Changes in this release |
||
Topic or section |
Brief description |
Reviewer |
New versions of the Standing Orders have been provided. |
Jenny Roberts |
|
Information has been added about when a terminal clean is required. |
Meghan Heaphy |
|
SCT Prescription Charts |
New versions of the Conditioning documents have been provided. |
Jenny Roberts |
This section has been reviewed. |
Mark Smith |
|
This section has been reviewed and updated. |
Steve Gibbons Vydia Mathavan |
|
The dosage for ursodiol under Management of VOD has been changed from 300 mg to 250 mg. |
Andrew Butler |
|
The note under CMV Monitoring has been updated. |
Andrew Butler |
|
This section has been reviewed and updated. |
Mark Smith |
|
This section has been reviewed and updated. |
Mark Smith |
|
The flowchart was updated so that 'alteplase' was used instead of 'Actilyse t-PA'. |
Jenny Roberts |
|
This section has been reviewed and updated. See the summary of changes for Plasma Cell Neoplasms |
Seán MacPherson |
|
There are new charts for the following. Acute Lymphoblastic Leukaemia:
|
Jenny Roberts |
|
A reference to Guidelines on the diagnosis and management of heparin-induced thrombocytopenia was added. |
Andrew Butler |
Topic Code: 122909